Editorial Policies

Focus and Scope

Drug Invention Today (DIT) is a monthly peer reviewed & open assess international  journal  publish original research works related to the following areas only

  • Target discovery
  • High-throughput screening
  • Novel therapeutic strategies
  • Rational drug design combinatorial and parallel synthesis
  • Key compound classes
  • Natural products
  • Genomics and proteomics
  • Automation and technology
  • Absorption, distribution, metabolism and elimination  of drugss
  • Virtual chemistry
  • Clinical trials of drugs
  • Business strategy of drugs
  • Bio-Informatics
  • Therapeutic targets
  • Microarrays
  • Pharmacogenomics and toxicogenomics
  • Pharmacology and toxicology
  • Biopharmaceuticals
  • Vaccines
  • Regulatory issues

The DIT publishes reviews, research articles and short communications. The scope of the journal is to publish above related areas. It is essential that authors prepare their manuscripts according to established specifications. Failure to follow them may result in papers being delayed or rejected. Therefore, contributors are strongly encouraged to read these instructions carefully before preparing a manuscript for submission. The manuscripts should be checked carefully for grammatical errors. All papers are subjected to peer review.

 

Section Policies

Articles

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Letter to editor

This section of will contain all the LETTER which peoples will write to editor and will be published along with every issue time to time. all the authors are requested to follow the author guideline and other policies will be same of DIT.

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Review articles

This section of will contain all the REVIEW articles  and will be published along with every issue time to time. all the authors are requested to follow the author guideline and other policies will be same of DIT.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Research articles

This section of will contain all the Research articles will be published along with every issue time to time. all the authors are requested to follow the author guideline and other policies will be same of DIT.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Short Notes

This section of will contain all the SHORT NOTES will be published along with every issue time to time. all the authors are requested to follow the author guideline and other policies will be same of DIT.

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

Scientific development requires the exchange and discussion of data and ideas. Drug Invention Today  is a unique publication dedicated to presenting the results of scientific and technical research from science ,Pharmacy and other discipline in an open-access background. The peer review of each article concentrates on objective and technical concerns to determine whether the research has been sufficiently well conceived, well executed, and well described to justify inclusion in the scientific evidence. Then, after publication, all papers are opened up for interactive discussions and evaluation in which the whole scientific and research community can be involved.Unlike many journals which attempt to use the peer review process to determine whether or not an article reaches the level of 'importance' required by a given journal, Drug Invention Today uses peer review to determine whether a paper is technically sound and worthy of inclusion in the published scientific record. Once the work is published in Drug Invention Today, the broader community is then able to discuss and estimate the significance of the articles. To provide open access, Open Access Drug Invention Today use a business model in which our expenses—including those of peer review, journal production, and online hosting and archiving—are recovered in part by charging a publication fee to the authors or research sponsors for each article they publish. For Drug Invention Today the publication fee is mentioned in the subscription section of Drug Invention Today. We also offer a complete or partial fee waiver for  few authors who do not have funds to cover publication fees. Editors and reviewers have no access to payment information, and hence inability to pay will not influence the decision to publish a paper. These policies ensure that the fee is never a barrier to publication. Drug Invention Today staff do not copyedit the text of accepted manuscripts; it is therefore important for the work, as presented, to be intelligible. Perfect, stylish English is not essential but the language must be clear and unambiguous. If the language of a paper is poor, Drug Invention Today reviewer should recommend that authors seek independent editorial help before submission of a revision.  Poor presentation and language is a justifiable reason for rejection.

Please note the authors When submitting an article, all authors are asked to indicate that they have not submitted a related manuscript for publication elsewhere. If similar or related work has been submitted elsewhere, then a copy must be included with the article submitted. Reviewers will be asked to comment on the overlap between related submissions.

Before submitting your manuscript, please collect information on the sources of funding that have supported the work. When you submit, you will be required to provide a statement in the online submission system or in manuscript text declaring the funding sources, and also stating the role of the study sponsor(s), if any, in study design; collection, analysis, and interpretation of data; writing of the paper; and decision to submit it for publication.Please also include the following statement, if pertinent: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed.

 

Publication Frequency

Drug Invention Today (DIT) is a monthly journal publishes, rapid communications, reviews, short communications and original research articles.

 

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

 

Archiving

This journal utilizes the LOCKSS system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration. More...

 

Drug Invention Today